絞り込み

18457

広告

ソフトバンクが配膳ロボットを発売 2021年1月に (財経新聞)

●飲食店で配膳・運搬を担うロボットを販売 ソフトバンクG傘下のソフトバンクロボティクスは28日、飲食店での配膳・運搬を担うロボット「Servi(サーヴィ)」を販...

  1. [企業] COVID-19入院患者へのC...
  2. 新型コロナ禍での緊急事態宣言には確かな効...
  3. [企業] 若年性特発性関節炎へのPfiz...
  4. 日本の「感染者バッシング」「マスク警察」...

ニュース一覧

「"Galsky MD "[Author]」の検索結果

262件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

mutation plus CXCL13 expression act as combinatorial biomarkers to predict responses to immune checkpoint therapy in mUCC.

Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors.

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.

Epithelial plasticity can generate multi-lineage phenotypes in human and murine bladder cancers.

Urothelial carcinoma: the development of FGFR inhibitors in combination with immune checkpoint inhibitors.

Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial.

Selective PP2A Enhancement through Biased Heterotrimer Stabilization.

Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial.

Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma.

Randomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial Cancer.

Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results.

Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study.

A reference profile-free deconvolution method to infer cancer cell-intrinsic subtypes and tumor-type-specific stromal profiles.

Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC).

Histologic Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study.

Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC).

First-line immune checkpoint inhibitor use in cisplatin-eligible patients with advanced urothelial carcinoma: a secular trend analysis.

Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with checkpoint inhibitors.

ENERGIZE: a Phase III study of neoadjuvant chemotherapy alone or with nivolumab with/without linrodostat mesylate for muscle-invasive bladder cancer.

Comparative Effectiveness of Robotic-Assisted Surgery for Resectable Lung Cancer in Older Patients.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります